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Membrane transporters are integral membrane proteins that mediate the 
passage of solutes across lipid bilayers. These proteins undergo 
conformational transitions between outward- and inward-facing states, 
which lead to alternating access of the substrate-binding site to the 
aqueous environment on either side of the membrane. Dozens of different 
transporter families have evolved, providing a wide variety of structural 
solutions to achieve alternating access. A sub-set of structurally diverse 
transporters operate by mechanisms that are collectively named “elevator-
type”. These transporters have one common characteristic: they contain a 
distinct protein domain that slides across the membrane as a rigid body, 
and in doing so it “drags” the transported substrate along. Analysis of the 
global conformational changes that take place in membrane transporters 
using elevator-type mechanisms reveals that elevator-type movements can 
be achieved in more than one way. Molecular dynamics simulations and 
experimental data help to understand how lipid bilayer properties may 






INTRODUCTION: MOVING BARRIERS AND ELEVATORS 
Structural studies of membrane transporters from diverse protein 
families have revealed that alternating access may be achieved in many 
ways (reviewed recently [1]). The so-called “moving barrier” mechanism is 
a frequently used solution (Figure 1). Proteins operating by this 
mechanism bind the transported substrate in a deep cavity, which is 
accessible to the aqueous environment from one side of the membrane 
only. A conformational change then closes off the access path to the binding 
site (gate closure), and opens up a new path to the other side of the 
membrane (gate opening). Moving barrier transporters thus work with 
two separate gates. Synchronization of opening and closing of the two 
gates is crucial: intermediate occluded states with both gates closed may 
be visited, but states with both gates open are prohibited. During the 
conformational transitions in the protein, the substrate remains bound at 
roughly the same position relative to the bilayer plane, until the 
conformational switching has been completed and a route to the aqueous 
solution on the opposite side of the membrane has opened. In many cases, 
the substrate-binding site is located halfway through the bilayer between 
two proteins domains that move around the substrate when switching 
between inward- and outward-facing states. The transport protein thus 
serves as a “moving barrier”. Prominent examples of proteins using a 
moving barrier mechanism include members of the major facilitator 
superfamily, in which two homologous protein domains swivel around the 
substrate as a rocker switch [2,3] (Figure 1a); the LeuT-fold proteins in 
which one protein domain moves as a rocking bundle relative to a fixed 
second (non-homologous) domain [4] (Figure 1b); and mitochondrial 
carriers, where three homologous domains pivot around the substrate in a 
concerted way as a diaphragm [5] (Figure 1c).  
The elevator-type transport mechanism offers an alternative solution to 
achieve alternating access [1]. Proteins using this mechanism consist of a 
moving and fixed domain (often termed “transport” and “scaffold” domain, 
respectively). Switching between outward- and inward-facing states 
involves the sliding of the entire transport domain through the bilayer as a 
rigid body. In contrast with proteins using a moving-barrier mechanism, 
the substrate-binding site translocates some distance across the bilayer 
during transport along with the transport domain (Figure 2). Because of 
the displacement of the substrate the elevator mechanism has been 
described as “moving carrier”. Alternatively, the name “fixed barrier 
mechanism” has been proposed [1], but as we will discuss below, some 
elevator proteins may not have a fixed barrier. Therefore, we prefer the 
names “elevator-type” or “moving carrier” mechanism. It is noteworthy 
that the classification of a transporter mechanism as “moving barrier” or 
“moving carrier” is based solely on the structural changes that take place in 
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the proteins during transport, and that it does not have predictive value for 
the transporter’s substrate specificity, coupling ion specificity (in 
secondary active transporters), or for the kinetic mechanism.  
 
 
Figure 1. Non-elevator type transporters. (a) moving barrier, rocker switch, exemplified 
by the fructose transporter GLUT5 with two protein domains (blue shades) rotating around 
substrate-binding site (orange circle) changing the barrier position (red bars) (PDB IDs for 
outward and inward states: 4YBQ and 4YB9). (b) moving barrier, rocking bundle, 
 34 
exemplified by the leucine transporter LeuT with transport domain (blue) moving relative 
to the scaffold domain (yellow). The substrate-binding site does not change its position 
relative to the membrane plane during the transition from outward to the inward state, but 
the barrier (red bar) does change (PDB IDs: 3TT1 and 3TT3). (c) the mitochondrial 
ADP/ATP carrier represents the moving-barrier, diaphragm mechanism, where three 
protein domains (blue shades) rotate around substrate-binding site changing the barrier 
position, indicated by the red bars (PDB IDs: 6GCI and 4C9H).  
 
 
The first elevator-type mechanism was described in 2009 for the 
aspartate transporter GltPh [6], a member of the glutamate transporter or 
SLC1 (Solute Carrier 1) family, but the name “elevator” was not used until 
2011 [7]. In recent years, elevator-type mechanisms have been proposed 
for numerous other proteins (Table 1). Many of the proteins shown in 
Table 1 are sodium-coupled secondary active transporters, but a sub-set of 
ATP-binding cassette (ABC) transporters, phosphotransferase system 
(PTS) transporters and unclassified transport proteins also appear to use 
elevator-type mechanisms. The abundant representation of secondary 
active transporters in Table 1 may simply be a reflection of the large 
number of families of secondary transporters that have evolved [8]. In this 
review, we focus on the global structural changes that take place in 
elevator-type membrane transporters. We do not discuss the kinetics of 
switching between outward- and inward-facing states, which may depend 
on the occupancy of the solute-binding site, or binding of compounds to 
allosteric sites, such as co-transported ion(s) in secondary active 
transporters, or nucleotides in ATP-binding cassette (ABC) transporters. 
For details of the intricate mechanisms of coupling of transport to co-ion 
translocation or ATP hydrolysis we refer to recent reviews [9–12].  
 
COMMON CHARACTERISTICS OF ELEVATOR-TYPE TRANSPORTERS  
In proteins using the elevator mechanism, the substrate moves some 
distance across the membrane during the conformational switching. In 
Table 1, the extent of the movement is indicated as the “vertical distance”, 
the displacement of the substrate in z-direction if the membrane plane is 
defined as the xy plane. In many cases, the domain movement is more 
complex than a simple translation, and the total distance over which the 
substrate is displaced is larger than the vertical distance (Table 1). 
Structurally, elevator-type membrane transporters show large diversity, 
indicating that the vertical movement can be realised in multiple ways, but 
many of the proteins have some characteristics in common. First, the 
transported substrates bind exclusively, or predominantly, to the transport 
domain, which is a prerequisite for joined movement of the transport 
domain and substrate, relative to the rigid scaffold domain. Second, in 
many cases the transport domain contains structural elements named 
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helical hairpins (HPs) that form the gates, which must be open to allow 
access of the substrate to the bindings site, and closed to make the elevator 
movement possible. An open gate prevents sliding of the transport domain 
relative to the scaffold domain because of steric incompatibility. Third, 
almost all proteins using elevator transport mechanisms have a membrane 
topology with inverted repeats [13], resulting in internal pseudosymmetry, 
which has been used to model the outward-facing conformation based on 
an inward-facing structure or vice versa [14–17]. Finally, elevator-type 
transport proteins are often homodimers or homotrimers. Subunit 
contacts in the oligomers are made exclusively by the scaffold domains, 
while the transport domains are located peripherally (Figure 3). It is not 
entirely clear what is the functional significance of the oligomeric state. For 
homotrimeric members of the glutamate transporter family, it has been 
shown that the three protomers function independently [18–25], but it is 
possible that cooperativity may occur in other protein families.  
Despite these similarities, global elevator movements and local gating 
motions vary widely between different protein families (Table 1). Using 
currently available structural data, elevator mechanisms can be classified 
into three types with pronounced differences in the way gating is achieved. 
The classification is based on proteins for which structures are available of 
multiple conformational states. For many of the proteins in Table 1, only a 
single structure has been solved, and therefore it is not yet possible to 
unambiguously classify them.  
 
FIXED BARRIER ELEVATOR WITH ONE GATE  
The glutamate transporter (SLC1) family of solute transporters is 
structurally well-characterized with 39 available structures of four 
different family members: the prokaryotic sodium-dependent aspartate 
transporters GltPh and GltTk, the human sodium- and potassium-dependent 
glutamate transporter EAAT1 (Excitatory Amino Acid Transporter 1), and 
the human neutral amino acid exchanger ASCT2 (Alanine Serine Cysteine 
Transporter 2) (Table 1 and reviewed in [26]). While GltPh is the 
prototypical elevator transporter, ASCT2 is the first SLC1 member, for 
which four key conformations have been resolved structurally: outward-
open, outward–occluded [27], inward-open [28] and inward–occluded 
[29]. We will use these structures to describe the one-gate, fixed barrier 







Figure 2. One- and two-gate elevators. (a) fixed barrier elevator with one gate. Neutral 
amino acid transporter ASCT2 (SLC1 family) (transport domain as blue ribbon; scaffold 
domain as yellow transparent surface) uses helical hairpin HP2 as a gate in both the 
outward state (it moves by 4 Å form the light pink closed (PDB ID: 6MPB) to the bright pink 
open conformation (PDB ID: 6MP6)) and in the inward state (8 Å movement from closed 
(PDB ID: 6GCT) to open position (PDB ID: 6RVX)). ASCT2 translocates substrate (orange 
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circle) relative to the membrane plane during transport (distances are indicated on the left), 
keeping the same contact (barrier) with the stable scaffold domain. (b) fixed barrier 
elevator with two gates. Concentrative nucleoside transporter CNT (SLC28 family) uses 
TM4b as an extracellular gate (5 Å movement from closed yellow (PDB ID: 5U9W, chain C) 
to open orange state (PDB ID: 5L2A, chain C)) and HP1 as an intracellular gate (6 Å 
movement from light pink closed (PDB ID: 5L26, chain A) to red open state (PDB ID: 5L27, 
chain A)). CNT is the only elevator transporter, for which multiple intermediate 
conformations have been resolved structurally, one of which is shown (PDB ID: 5L24, chain 
C). (c) moving barrier elevator with two gates. The bile acid transporter ASBT (SCL10 
family) provides access to the binding site (indicated by arrows within the circle) using 
bundle movements of the transport domain (PDB ID: 4N7X and 3ZUX), during which barrier 
(red bar) is changing. (d) other elevator with one gate. Energy coupling factor folate 
transporter ECF-FolT (ECF-type (type III) ABC importer) has loop 1 (L1) and loop 3 (L3) in 
the S-component (blue ribbon) that provide access to the substrate-binding site from the 
extracellular (PDB ID: 5D0Y) and the intracellular side (PDB ID: 5JSZ). The EcfT subunit is in 
yellow transparent surface, and the ATPase subunits are omitted for clarity.  
 
 
Like all members of the SLC1 family, neutral amino acid transporter 
ASCT2 is a homotrimer. Each monomer consists of 8 transmembrane 
segments (TMs) that form a scaffold domain (TM1–2, TM4–5) and a 
transport domain (TM3, TM6–8). The transport domain additionally 
contains two helical hairpins (HP1 and HP2). In the outward-facing states 
the substrate-binding site is close to the extracellular side of the 
membrane, and the only difference between open and closed 
conformations is the position of HP2, which works as a gate to provide 
access to the binding site from the extracellular aqueous environment [27] 
(Figure 2a). When the gate is closed, the transported substrate is occluded 
within the transport domain, which makes the elevator movement 
possible. The binding site relocates by a distance of ∼19 Å perpendicular to 
the membrane plane between the outward- to the inward-facing 
orientation. Strikingly, HP2 was also found to be the gate on the 
intracellular side, hence the name one-gate elevator mechanism [28]. HP1 
plays a role in substrate coordination in the binding site, but in contrast 
with HP2, it does not change its conformation during the transport cycle. 
The scaffold domain has two highly tilted helices (TM2 and TM5) along 
which the transport domain slides. These helices determine the minimal 
distance that the substrate-binding site must travel, and have been named 
the fixed barrier [1].  
The fixed barrier elevator mechanism with one gate is likely conserved 
among the SLC1 family, as evidenced by recent single particle cryo-EM 
structures of GltTk [30], and molecular dynamics simulations of GltPh [7]. 
Fixed barrier elevators with one gate may also occur in other families of 
transporters, for which the number of structurally resolved states is not as 
large as for the SLC1 family. Transporters of the Phosphotransferase 
System (PTS), which are responsible for the uptake and phosphorylation of 
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carbohydrates and other compounds such as ascorbate (reviewed in [31]) 
have characteristic elevator elements, such as transport and scaffold 
domains, HP gates, and homo-oligomer architecture. Structures of MalT 
[32,33] and ChbC [34] indicate that they use a fixed barrier and most likely 
a single gate.  
ATP-binding Cassette (ABC) transporters do not use elevator-type 
mechanisms of transport, with the exception of the non-canonical 
subfamily of ECF (energy-coupling factor) transporters. ECF transporters 
are involved in uptake of vitamins or other micronutrients (reviewed in 
[11]). Two sub-types exist (Group I and II) which may differ in the 
mechanistic details, but the ensemble of available structural information is 
consistent with elevator-type behaviour in all ECF transporters. ECF 
transporters make use of an integral membrane subunit named the S-
component that binds the transported substrate on the extracellular side of 
the membrane (Figure 2d). In many cases, access to the binding site is 
controlled by two loops, which act as gate (loop 1 and loop 3). In the bound 
state, with closed gate, the substrate is occluded and the S-component can 
“topple over” in the membrane, which brings the substrate-binding site to 
the cytoplasm. In the toppled state the same loops 1 and 3 can move to 
expose the binding site to the cytoplasm (similar to a one-gate elevator). 
The S-component may be considered as the equivalent of the transport 
domain, whereas the counterpart of the scaffold domain is a second 
integral membrane subunit, named EcfT or T-component (Figure 2d). The 
use of separate subunits instead of linked domains provides extra 
functionality, as dissociation and association are part of the transport cycle 
in some ECF transporters [35]. The EcfT subunit is additionally associated 
with ATPase subunits for allosteric coupling of the conformational changes 
to ATP binding and hydrolysis, which are the hallmark of ABC transporters.  
 
FIXED BARRIER ELEVATOR WITH TWO GATES  
The concentrative nucleoside transporter CNT (a member of the SLC28 
family) is a homotrimer [36], with each monomer subdivided into a 
transport domain (TM1–2, TM4–5, TM7–8 and HP1, HP2) and a scaffold 
domain (TM3 and TM6). In this case, the binding site for the nucleoside is 
located at the interface between scaffold and transport domains, but most 
of the interactions with the substrate come from the residues in the 
transport domain. CNT uses different gates on the extra- and intracellular 
sides [36] (Figure 2b). Comparison of structures of CNT in outward-open 
and outward-closed states revealed different conformations of TM4b, 
suggesting that this half-TM is an extracellular gate. On the intracellular 
side, HP1b is the movable element, which gates access to the binding site. 
The transitions between the outward- and inward-facing states involve a 
∼8 Å translocation of the substrate-binding site (perpendicular to the 
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membrane plane), in which it passes a fixed barrier formed by TM3 and 
TM6 of the scaffold domain. CNT is the only elevator transporter, for which 
multiple intermediate conformations, where the position of transport 
domain is distributed between the inward and outward states, have been 
resolved structurally.  
 
 
Figure 3. Oligomeric state of elevator transporters. (a) monomeric bile acid transporter 
ASBT (PDB ID: 3ZUX), (b) dimeric citrate transporter SeCitS (PDB ID: 5A1S) and (c) 
trimeric glutamate transporter GltPh (PDB ID: 2NWW) viewed from the extracellular side of 
the membrane. Transport domains in blue, scaffold domains in yellow.  
 
 
It is possible that the location of the binding site between two domains 
in CNT necessitates the use of two gates, whereas an occluded binding site 
within the transport domain, as found in SLC1 transporters, may allow the 
use of a single gate. Most of the transporters with proposed elevator-like 
transport mechanisms have substrate-binding sites positioned at the 
interface of two domains (Table 1). Transporters of AbgT family [37] and 
the structurally related Na+/succinate transporter VcINDY [14] (DASS 
family), the Na+/citrate transporter SeCitS [38] (2HCT family), anion 
exchanger 1 (AE1), a member of SLC4 family [39] and the structurally 
related uracil:proton symporter UraA [40,41] from SLC23 family (seven 
transmembrane segment inverted repeat [42]), and bicarbonate 
transporter BicA [43] of the SLC26 family are organized in two domains 
(transport and scaffold) and bind the substrate at the domain interface. All 
of these proteins may use an elevator mechanism with fixed barrier and 
two gates [37], but additional structural characterization is needed to 
classify the gating mechanism of these transporters.  
 
MOVING BARRIER ELEVATOR WITH TWO GATES  
The bile acid transporter ASBT, and structurally related sodium-proton 
antiporters have 10 and 13 transmembrane helices respectively, with a 
transport domain (also called core domain) consisting of TM3–5, TM8–10 
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in ASBT (TM3–5, TM10–12 in sodium-proton antiporters), and a scaffold 
domain (TM1–2, TM6–7 in ASBT or TM1–2, TM7–9 in sodium-proton 
antiporters). Despite the movement of the substrate-binding site across the 
membrane during sliding of the transport domain relative to the scaffold 
(the hallmark of the elevator mechanism), ASBT does not have a fixed 
barrier (Figure 2c). Thus, this transporter combines an elevator movement 
with a moving barrier, which is a typical feature of non-elevator-type 
mechanisms (Figure 1) [44]. Unlike most other elevator transporters, ASBT 
and the related sodium-proton antiporters NapA and NhaA do not have 
helical hairpins. Possibly HPs are suitable for gating when a fixed barrier is 
used, but are not required for moving barrier elevators (Figure 2c).  
ASBT is exceptional among elevator-type transporters because it is a 
monomeric protein. Another monomeric transporter, for which an elevator 
mechanism has been postulated, is CcdA [17]. CcdA is the smallest 
elevator-type protein and is involved in the transport of reducing 
equivalents from the cytoplasm to the extracellular environment, by using 
a pair of cysteine residues that can be oxidized to form a disulfide bridge. 
The protein consists of six transmembrane helices, which are organized in 
two inverted structural repeats [17]. Comparison of the outward-facing 
conformation, solved using NMR spectroscopy, and inward-facing 
conformation, which was computationally modelled using information 
from the inverted topology, showed that protein forms a unique “O-shaped 
scaffold” in the center of which TM1 and TM4 may move as an elevator 
between inward- and outward-facing states with the active-site cysteines 
bridging a distance of 12 Å [17]. Structural information on CcdA is still very 
limited, and further work is required to confirm the elevator mechanism.  
 
LIPID ENVIRONMENT AND ALLOSTERIC INHIBITION  
It has been noticed that the TMs of the scaffold domains of many 
elevator-type transporters are shorter than those in transport domains, 
and often highly tilted [1]. As a consequence, the distance between the 
external and internal aqueous solutions is substantially smaller than the 
thickness of the bulk bilayer. Such thinning not only reduces the extent of 
elevator movement required to transfer the substrate between the 
aqueous solutions on either side of the membrane, but may also induce 
membrane distortion, which in turn could facilitate the sliding movement 
of the transport domain. Molecular dynamic simulations of ECF 
transporters in a lipid bilayer predict possible membrane distortion near 
the EcfT scaffold, which might facilitate toppling of the S-component when 
it is near the scaffold [11,45]. Recent MD simulations of a lipid bilayer 
around GltPh show different extents of membrane deformation depending 
on the position of the transport domain [46] (Figure 4a). Protomers of GltPh 
in the outward-facing state induce very little local membrane curvature 
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[46], but the lipid bilayer strongly bends around protomers in the inward-
facing state. The energetic penalty of such deformation may be balanced by 
specific protein–lipid interactions.  
 
 
Figure 4. Lipids and elevator transporters. (a) deformation of the lipid bilayer around 
glutamate transporter GltPh (PDB ID: 3KBC), when all protomers are in the inward-facing 
state (adapted from ref. [46]). (b) non-protein densities (orange mesh) observed in the 
neutral amino acid transporter ASCT2 cryo-EM map (EMD-10016) are located at the 
interface of the transport (blue) and scaffold (yellow) domains and highlighted with a red 
circle (PDB ID: 6RVX). (c) allosteric inhibitor UCPH101 (orange sticks) in excitatory amino 
acid transporter EAAT1 (PDB ID: 5LLM).  
 
 
Most structures of elevator-type transporters have been determined in 
the absence of a lipid bilayer, using detergent-solubilized proteins, which 
precludes accurate analysis of the protein–lipid interface. Nonetheless, 
these structures can provide indications of specific lipid-binding sites 
(Figure 4). For example, many non-protein densities were found in 
structures of ASCT2 determined by single particle cryo-electron 
microscopy (Figure 4b). These densities likely correspond to phospholipid 
molecules or cholesterol, although unambiguous identification was not 
possible at the attained resolution. The observed densities were located 
around the entire perimeter of the scaffold domain, also in the space 
between transport and scaffold domains, and close to the substrate binding 
site [28,29]. Lipids binding at these positions could be important for 
protein stability and might allosterically affect protein activity. A crystal 
structure of EAAT1 in the presence of the allosteric inhibitor UCPH101 
demonstrated that the inhibitor’s binding site is located between transport 
and scaffold domains [47], exactly where a putative cholesterol molecule 
was observed in ASCT2 [27–29] (Figure 4c). Also in other families of 
elevator-type transporters, lipids were found to intercalate between the 
scaffold and transport domains [38,48]. These observations indicate that 
specific lipid–protein interactions might affect elevator-like movements of 
the transporter, and that lipid-binding sites may be targeted for drug 
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design.  
In only very few cases have the effects of the lipid environment been 
studied experimentally. In GltPh the relation between lipid composition and 
transport activity was studied in proteoliposomes. The activity of GltPh was 
higher in liposomes containing the non-bilayer lipid 
Phosphatidylethanolamine (PE), than in liposomes composed of 
Phosphatidylcholine (PC) [49]. This effect may be caused by specific 
interactions between the protein and lipid headgroups, or by colligative 
properties of the bilayer such as lipid disorder, both of which could affect 
the elevator-type movements. For ASCT2, glutamine uptake activity in 
proteoliposomes was enhanced by the presence of cholesterol [29], but 
again it has not been established whether this effect is due to binding of 
cholesterol at specific sites, or to colligative effects such as thickness or 
fluidity. Lipid interactions are also essential for dimer stability of NhaA, 
which falls apart to monomers in the presence of high detergent 
concentrations, but is assembled back if cardiolipin is added [50]. In vivo, 
allosteric modulation by lipid molecules has been observed in Xenopus 
oocytes expressing EAAT4 that displayed increased glutamate-induced 
currents when arachidonic acid was added [51]. The presence of 
cholesterol was found to be crucial for functioning and localization of 
EAAT2 [52].  
The above examples show that lipids may affect protein function directly 
via interactions with amino acid residues, which could accelerate or slow 
down transport domain movements or stabilize the scaffold domain in the 
membrane. In addition, colligative bilayer properties are likely to affect the 
functioning of elevator-type transporters, because the lipid–protein 
interface must rearrange substantially during transport. Finally, also the 
domain structure of the proteins may affect the bilayer morphology, and 
consequently elevator dynamics.  
 
PERSPECTIVES  
1. Importance of the field. Since the first description of an elevator-
type transport mechanism for GltPh over a decade ago [6], a variety of 
protein folds have emerged that support elevator movements, not only in 
secondary active transporters but also in different transporter classes 
(Table 1). Many of these transporters are potential targets in 
pharmacological studies and understanding of their transport and gating 
mechanisms might help with the development of new drugs.  
2. A summary of the current thinking. In elevator-type transport 
mechanisms, one protein domain brings the substrate-binding site from 
one side of the membrane to the other by sliding through the lipid bilayer. 
The extent of the elevator movement, ranging from 21 Å in GltTk to 7.5 Å in 
ASBT, and number of gating elements (one or two) vary between different 
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proteins (Table 1).  
3. Future directions. Local deformations of the lipid bilayer near 
elevator-type transporters, which were observed in MD simulations [46], 
can be studied experimentally by single particle cryo-electron microscopy, 
using transporters reconstituted in lipid environment [30], similar to what 
has been done for the lipid scramblase TMEM16 [53]. Also systematic 
analysis of the relationship between lipid composition, transport activity 
and dynamics (for instance by single molecule FRET methods [18,54]) will 
shed further light on the interplay between bilayer and protein. The gating 
behaviour might affect the order of binding and release of coupled ions and 
a substrate, and steady state and pre-steady state kinetic measurements 
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